Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Currently, there are no approved medications for treating nonmonogenic, nonsyndromic obesity in children under 12. While ...

Researchers used real-world data to identify key factors for long-term weight loss for patients taking GLP-1 drugs like Ozempic and Wegovy.

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

A study of children aged six to 12 suggests that the active ingredient liraglutide is effective and safe in children. So far there's nothing on the market to help obese kids, according to Daniel ...

Liraglutide results in greater reduction in BMI than placebo plus lifestyle intervention for children with obesity ...

In people with Type 2 diabetes, obesity, and chronic kidney disease, bariatric or weight loss surgery can significantly ...